409 related articles for article (PubMed ID: 29678354)
1. Actin dynamics at focal adhesions: a common endpoint and putative therapeutic target for proteinuric kidney diseases.
Sever S; Schiffer M
Kidney Int; 2018 Jun; 93(6):1298-1307. PubMed ID: 29678354
[TBL] [Abstract][Full Text] [Related]
2. Role of γ-adducin in actin cytoskeleton rearrangements in podocyte pathophysiology.
Gao W; Liu Y; Fan L; Zheng B; Jefferson JR; Wang S; Zhang H; Fang X; Nguyen BV; Zhu T; Roman RJ; Fan F
Am J Physiol Renal Physiol; 2021 Jan; 320(1):F97-F113. PubMed ID: 33308016
[TBL] [Abstract][Full Text] [Related]
3. Pdlim2 is a novel actin-regulating protein of podocyte foot processes.
Sistani L; Dunér F; Udumala S; Hultenby K; Uhlen M; Betsholtz C; Tryggvason K; Wernerson A; Patrakka J
Kidney Int; 2011 Nov; 80(10):1045-54. PubMed ID: 21814175
[TBL] [Abstract][Full Text] [Related]
4. Signaling in regulation of podocyte phenotypes.
Chuang PY; He JC
Nephron Physiol; 2009; 111(2):p9-15. PubMed ID: 19142027
[TBL] [Abstract][Full Text] [Related]
5. Targeting podocyte-associated diseases.
Leeuwis JW; Nguyen TQ; Dendooven A; Kok RJ; Goldschmeding R
Adv Drug Deliv Rev; 2010 Nov; 62(14):1325-36. PubMed ID: 20828590
[TBL] [Abstract][Full Text] [Related]
6. Podocyte mitosis - a catastrophe.
Lasagni L; Lazzeri E; Shankland SJ; Anders HJ; Romagnani P
Curr Mol Med; 2013 Jan; 13(1):13-23. PubMed ID: 23176147
[TBL] [Abstract][Full Text] [Related]
7. Understanding the podocyte immune responses in proteinuric kidney diseases: from pathogenesis to therapy.
Jiang H; Shen Z; Zhuang J; Lu C; Qu Y; Xu C; Yang S; Tian X
Front Immunol; 2023; 14():1335936. PubMed ID: 38288116
[TBL] [Abstract][Full Text] [Related]
8. Plekhh2, a novel podocyte protein downregulated in human focal segmental glomerulosclerosis, is involved in matrix adhesion and actin dynamics.
Perisic L; Lal M; Hulkko J; Hultenby K; Önfelt B; Sun Y; Dunér F; Patrakka J; Betsholtz C; Uhlen M; Brismar H; Tryggvason K; Wernerson A; Pikkarainen T
Kidney Int; 2012 Nov; 82(10):1071-83. PubMed ID: 22832517
[TBL] [Abstract][Full Text] [Related]
9. The podocyte's response to injury: role in proteinuria and glomerulosclerosis.
Shankland SJ
Kidney Int; 2006 Jun; 69(12):2131-47. PubMed ID: 16688120
[TBL] [Abstract][Full Text] [Related]
10. Synaptopodin protects against proteinuria by disrupting Cdc42:IRSp53:Mena signaling complexes in kidney podocytes.
Yanagida-Asanuma E; Asanuma K; Kim K; Donnelly M; Young Choi H; Hyung Chang J; Suetsugu S; Tomino Y; Takenawa T; Faul C; Mundel P
Am J Pathol; 2007 Aug; 171(2):415-27. PubMed ID: 17569780
[TBL] [Abstract][Full Text] [Related]
11. Podocyte injury and targeting therapy: an update.
Durvasula RV; Shankland SJ
Curr Opin Nephrol Hypertens; 2006 Jan; 15(1):1-7. PubMed ID: 16340659
[TBL] [Abstract][Full Text] [Related]
12. Actin up: regulation of podocyte structure and function by components of the actin cytoskeleton.
Faul C; Asanuma K; Yanagida-Asanuma E; Kim K; Mundel P
Trends Cell Biol; 2007 Sep; 17(9):428-37. PubMed ID: 17804239
[TBL] [Abstract][Full Text] [Related]
13. Connective tissue growth factor modulates podocyte actin cytoskeleton and extracellular matrix synthesis and is induced in podocytes upon injury.
Fuchshofer R; Ullmann S; Zeilbeck LF; Baumann M; Junglas B; Tamm ER
Histochem Cell Biol; 2011 Sep; 136(3):301-19. PubMed ID: 21814837
[TBL] [Abstract][Full Text] [Related]
14. Zyxin is important for the stability and function of podocytes, especially during mechanical stretch.
Kliewe F; Siegerist F; Hammer E; Al-Hasani J; Amling TRJ; Hollemann JZE; Schindler M; Drenic V; Simm S; Amann K; Daniel C; Lindenmeyer M; Hecker M; Völker U; Endlich N
Commun Biol; 2024 Apr; 7(1):446. PubMed ID: 38605154
[TBL] [Abstract][Full Text] [Related]
15. Podocyte Geranylgeranyl Transferase Type-I Is Essential for Maintenance of the Glomerular Filtration Barrier.
Boi R; Bergwall L; Ebefors K; Bergö MO; Nyström J; Buvall L
J Am Soc Nephrol; 2023 Apr; 34(4):641-655. PubMed ID: 36735952
[TBL] [Abstract][Full Text] [Related]
16. New insights into the role of podocytes in proteinuria.
Patrakka J; Tryggvason K
Nat Rev Nephrol; 2009 Aug; 5(8):463-8. PubMed ID: 19581907
[TBL] [Abstract][Full Text] [Related]
17. Changes of podocyte p130Cas in diabetic conditions.
Ha TS; Choi JY; Park HY; Han GD
J Nephrol; 2013; 26(5):870-6. PubMed ID: 23559070
[TBL] [Abstract][Full Text] [Related]
18. Vitamin D down-regulates TRPC6 expression in podocyte injury and proteinuric glomerular disease.
Sonneveld R; Ferrè S; Hoenderop JG; Dijkman HB; Berden JH; Bindels RJ; Wetzels JF; van der Vlag J; Nijenhuis T
Am J Pathol; 2013 Apr; 182(4):1196-204. PubMed ID: 23385000
[TBL] [Abstract][Full Text] [Related]
19. Role of dynamin, synaptojanin, and endophilin in podocyte foot processes.
Soda K; Balkin DM; Ferguson SM; Paradise S; Milosevic I; Giovedi S; Volpicelli-Daley L; Tian X; Wu Y; Ma H; Son SH; Zheng R; Moeckel G; Cremona O; Holzman LB; De Camilli P; Ishibe S
J Clin Invest; 2012 Dec; 122(12):4401-11. PubMed ID: 23187129
[TBL] [Abstract][Full Text] [Related]
20. Podocytes are firmly attached to glomerular basement membrane in kidneys with heavy proteinuria.
Lahdenkari AT; Lounatmaa K; Patrakka J; Holmberg C; Wartiovaara J; Kestilä M; Koskimies O; Jalanko H
J Am Soc Nephrol; 2004 Oct; 15(10):2611-8. PubMed ID: 15466265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
